Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: Relation to prognostic variables

Indian Journal of Pathology and Microbiology

Volumn 56, Issue 2, 2013, Pages 89-93

  Helal, Thanaa E A ^a   Ibrahim, Eman A A ^a   Alloub, Amal I A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Breast cancer; CD20+; CD3+; CD4+; CD8+; lymphocytes

Indexed keywords

CD8 ANTIGEN; PARAFFIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BREAST CARCINOMA; BREAST LESION; CANCER PROGNOSIS; CANCER STAGING; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; B-LYMPHOCYTES; BREAST NEOPLASMS; CARCINOMA, DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 84885416487     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.118676     Document Type: Article

References (34)

1. An T, Sood U, Pietruk T, Cummings G, Hashimoto K, Crissman JD. In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Am J Pathol 1987;128:52-60.
2. Menard S, Tomasic G, Casalini P, Balsari A, Pilotti S, Cascinelli N, et al. Lymphoid infiltration as a prognostic variable for early-onset breast carcinoma. Clin Cancer Res 1997;3:817-9.
3. Marsigliante S, Biscozzo L, Marra A, Nicolardi G, Leo G, Lobreglio GB, et al. Computerized counting of tumour infiltrating lymphocytes in 90 breast cancer specimens. Cancer Lett 1999;139:33-41.
4. Coronella JA, Spier C, Welch M, Trevor KT, Stopeck AT, Villar H, et al. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol 2002;169:1829-36.
5. Mooe OS, Foote FW Jr. The relatively favorable prognosis of medullary carcinoma of the breast. Cancer 1949;2:635-42.
6. Black MM, Barclay TH, Hankey BF. Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer 1975;36:2048-55.
7. Hamin IM. Possible host resistance in carcinoma of the breast. Br J Cancer 1986;22:382-401.
8. Macchetti AH, Marana HR, Silva JS, Andrade JM, Ribeiro-Silva A, Bighetti S. Tumor-infiltrating CD4+ lymphocytes in early breast cancer reflect lymph node involvement. Clinics 2006;61(Suppl 3):203-8.
9. Matkowski R, Gesterek I, Halon A, Lacko A, Szewczyk K, Staszek U, et al. The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res 2009;29(Suppl 7):2445-51.
10. Chin Y, Janseens J, Vandepitte J, Vandenbrande J, Opdebeek L, Raus J. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res 1992;12(Suppl 5):1463-6.
11. Ben-Hur H, Cohen O, Schneider D. The role of lymphocytes and macrophages in human breast tumorigenesis: An immunohistochemical and morphometric study. Anticancer Res 2002;22:1231-8.
12. Balc CM, Riley LB, Bae YJ, Salmeron MA, Paltsoucas CD, Von Eschenbach A, et al. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 1990;125:200-5.
13. Wang B, Springer GF, Kaufman MW. Concurrent immunohistochemical staining of tumor-infiltrating lymphocytes and carcinoma-associated T (Thomson-Friedenreich)/Tn antigens in human breast carcinoma. J Histochem Cytochem 1996;44:187-91.
14. Naukkarinen A, Syrjanen KJ. Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas-correlation with tumour differentiation. J Pathol 1990;160:217-22.
15. Sheu BC, Kuo WH, Chen RJ, Huang SC, Chang KJ, Chow SN. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. Breast 2008;17(Suppl 6):604-10.
16. Edge B, Brgrd DR, Coducci MA, Compton CC, editors. AJCC cancer staging manual. 7 th ed. New York, NY: Springer;2009.
17. Bloom HJ, Richardson WW. Histological grading and prognosis in breast carcinoma. Br J Cancer 1957;11:359-77.
18. Hsu S, Raine L. Protein, avidin and biotin in immunohistochemistry. J Histochem Cytochem 1981;29:1349-53.
19. Kreike B, Van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bortlnk H, et al. Gene expression profiling and histopathological characterization of triple-negative/basal like breast carcinoma. Breast Cancer Res 2007;9:R65.
20. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009;30:1073-81.
21. Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 2008;68:5405-13.
22. Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, et al. Immunogenic cancer cell death: A key-lock paradigm. Curr Opin Immunol 2008;20:504-11.
23. Zitvogel L, Kroemer G. Introduction. The immune response against dying cells. Curr Opin Immunol 2008;20:501-3.
24. Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007;67:9518-27.
25. Hussein MR, Hassan HI. Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: Preliminary observations. J Clin Pathol 2006;59:972-7.
26. McDermott RS, Beuvon F, Pauly M, Pallud C, Vincent-Salomon A, Mosseri V, et al. Tumor antigen-presenting capacity in breast cancer. Pathobiology 2002;70:324-32.
27. Jager E, Jager D, Knuth A. Strategies for the development of vaccines to treat breast cancer. Recent Results Cancer Res 1998;152:94-102.
28. Camp BJ, Dyhrman ST, Memoli VA, Mott LA, Barth RJ Jr. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Ann Surg Oncol 1996;3:176-84.
29. Nzula S, Going JJ, Stott DI. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 2003;63:3275-80.
30. Simsa P, Teillaud LL, Stott DI, Toth J, Kotlan B. Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal brest carcinoma. Pathol Oncol Res 2005;11(Suppl 2):92-7.
31. Mahmoud S, Lee A, Ellis I, Green AR. Cd8+ T lymphocytes infiltrating reast cancer A promising new prognostic marker? Oncoimmunology 2012;1:1-2.
32. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces Th 1 polarization. J Immunol 2004;172:4618-23.
33. Shimokawara I, Imamura M, Yamanaka N, Ishii Y, Kikuchi K. Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: An immunoperoxidase study with anti-human T-and B-cell sera. Cancer 1982;49:161-72.
34. Lee AH, Happerfield LC, Bobrow LG, Millis RR. Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol 1997;50:669-73.